Skip to main content

BNP PARIBAS ARBITRAGE, SA

Position in PCRX — Pacira BioSciences, Inc.

CIK 1166588 NEW YORK, NY

Position in PCRX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,506,597
+$1,114,465 QoQ
Shares Held
59,385
+242.3% QoQ
Ownership
0.149%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#79
of 254 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in PCRX Over Time

Shares Held

Position Value (USD)

Derivatives in PCRX

reported options exposure · as of Mar 31, 2025
CallValue
$0
CallShares
0
PutValue
$4,125
PutShares
166

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

BNP PARIBAS ARBITRAGE, SA holds $502,986,525 across 54 Drug Manufacturers - Specialty & Generic names. PCRX ranks #25 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PCRX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,506,597 59,385
2026-03-31 $392,132 17,351
2025-12-31 $2,885,024 111,477
2025-09-30 $2,144,321 83,210
2025-06-30 $469,539 19,646
2025-03-31 $4,138,022 166,520
2025-03-31 $4,125 166
2024-12-31 $4,177,562 221,739
2024-09-30 $5,955,209 395,695
2024-06-30 $3,062,214 107,033
2024-03-31 $2,569,489 87,936
2023-12-31 $2,918,240 86,492
2023-09-30 $3,140,466 102,362
2023-06-30 $4,470,529 111,568
2023-03-31 $1,294,656 31,724
2022-12-31 $447,219 11,583
2022-06-30 $710,910 12,194
2022-03-31 $1,446,416 18,952
2021-12-31 $1,771,464 29,441
2021-09-30 $2,391,256 42,701
2021-06-30 $938,294 15,463
2021-03-31 $602,003 8,589
2020-12-31 $579,311 9,681
2020-09-30 $681,039 11,328
2020-06-30 $187,422 3,572
2020-03-31 $6,536,237 194,937